November 2012 | AIChE

Other Sites & Tools

Technical Groups

You are here

November 2012

Analytical Development and Product Characterization Strategies

In this session talks will be focused on new, more streamlined approaches to analytical method development and transfer for both product release and characterization. Examples would include eliminating some product release assays through more powerful MS methods, using platform analytic

Integrating Process Development: Upstream and Downstream Technology

Talks in this session will include new approaches to process development in both upstream and downstream areas that together present significant improvements to speed in the development and implementation of commercial drug substance processes. The use of automation and high-throughput syste

Expression Systems

The focus of this session will be the use of expression systems to significantly accelerate development and eventual commercialization of protein therapeutics.  Talks might include discussion of current use (or potential use) of novel expression systems for this purpose, or the use of conve

Sustainability Credentials Pre-Screening Survey

Massively Parallel Computing and Massive Impacts for ChE [Blog Series]

November 29, 2012
This is Part 9 in the ChEnected series "We Are ChE: Entering a Golden Age". It is authored by Incoming 2013 AIChE president Phil Westmoreland.

Massively Parallel Computing and Massive Impacts for ChE

November 29, 2012
November 29, 2012

In this week’s post about the new Golden Age of ChE, Phil Westmoreland writes about “Massively parallel computing and massive impacts for ChE.”

Martin Allen

Martin is currently an Associate Research Fellow in the Cell Line Development group at Pfizer in Andover, MA.  Prior to joining Pfizer Martin was a member of the Cell Line Development groups at Wyeth, Amgen, and Immunex.  Martin holds a PhD in Molecular Biology and completed postdoctoral training at the National Jewish Medical and Research Center in Denver, CO....Read more

Accelerating Biopharmaceutical Development

This session will set the context and tone for the AccBio meeting and can be structured as case studies and/or a panel discussion where technologies and approaches are examined that have been successfully implemented to accelerate development and commercialization of protein therapeutics. Ex

Become a Sponsor

How Do Sponsors Benefit? You put your organization in front of a select, elite audience, to powerfully communicate your company's message You generate new contacts, and renewed interest for your products You demonstrate your company's support for technical excellence as a supplier and employer...

Registration Info

Online Registration is Now Closed You can register on-site in San Antonio at the Grand Hyatt (4th Level), beginning Sunday April 28th at 7AM. See Map Registration Categories Early-bird (Ended 3/11) Standard (Ends 4/25) On-Site: member non member non member non GCPS Bundle & Recordings** $995 $...

Pages